Drug
Stat Inhibitor Opb 111077
Stat Inhibitor Opb 111077: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| STAT Inhibitor OPB-111077 NCT03063944 | Phase 1 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Stat Inhibitor Opb 111077 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.